PedAM
Pediatric Disease Annotations & Medicines
| Disease | chronic lymphocytic leukemia |
| Symptom | C0021311|infections |
| Sentences | 6 |
| PubMedID- 23799400 | Pathogenesis, prophylaxis and treatment of infections in patients with chronic lymphocytic leukemia. |
| PubMedID- 26337493 | Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. |
| PubMedID- 21959050 | Considering the successful combined modality of immunosuppressive therapy with csa and pdn-based regimens in preventing acute rejection in organ transplantation and the effect of intravenous immunoglobulin on preventing infections in patients with chronic lymphocytic leukemia, we postulated that patients who have failed first-line chop (cyclophosphamide, doxorubicin, vincristine, and pdn) or chop-like regimens might benefit from long-term treatment with a combination of csa, pdn, and a monthly high-dose intravenous immunoglobulin (hdivig), which may help reduce the risk of infection during therapy. |
| PubMedID- 22774920 | Immunoglobulin g (igg) preparations are approved by the us food and drug administration for the treatment of primary immunodeficiency disease, idiopathic thrombocytopenic purpura, kawasaki disease, chronic lymphocytic leukemia with frequent infections, bone marrow transplantation, to prevent infection in pediatric human immunodeficiency virus, and chronic inflammatory demyelinating polyneuropathy. |
| PubMedID- 24144314 | Toll-like receptor 4 and 9 expression in b-chronic lymphocytic leukemia: relationship with infections, autoimmunity and disease progression. |
| PubMedID- 24619633 | Hepatitis b and hepatitis c viral infections in patients with chronic lymphocytic leukemia. |
Page: 1